Decoding ROS1 Fusions in Lung Cancer

Episode
158
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses ROS+1 Fusions in NSCLC, including diagnosis, treatment, and new exciting research coming down the pipeline.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Shirish M. Gadgeel
Shirish Gadgeel

MD

Chief, Division of Hematology and Oncology, Department of Internal Medicine
Henry Ford Cancer Institute
Henry Ford Health System
Lorenza Landi
Lorenza Landi

MD

Director of Clinical Trials Unit: Phase 1 and Precision Medicine
National Cancer Institute Regina Elena in Rome